He is a Global Safety Senior Manager at Amgen with over 23 years of experience in the pharmaceutical and healthcare industries. He has held leadership roles in pharmacovigilance, medical affairs, clinical research, quality assurance, and compliance across Amgen, Pfizer, Takeda in the Middle East and Africa countries (MEA).

Dr Eslam is a strategic thinker and subject matter expert in drug safety, risk management, and audit and inspection readiness. He has successfully led regional and global pharmacovigilance projects, ensuring compliance with regulatory requirements and internal policies. With a Master’s degree in Pharmacovigilance and Pharmacoepidemiology from the University of Bordeaux, France, Dr. Eslam combines academic expertise with hands-on experience in shaping safety regulations, crisis management, and operational efficiency.

Additionally, Dr. Eslam was one of the Pharmacovigilance Association in Middle East (PHAME) founder in 2015.His contributions have been recognized through invitations as a speaker at pharmacovigilance conferences and advisory roles with health authorities. Dr. Eslam is passionate about patient safety, innovation, and leadership development, continuously striving to enhance drug safety processes and industry standards.